Stern, Peter L.
Harrop, Richard http://orcid.org/0000-0001-6599-557X
Article History
Received: 6 July 2016
Accepted: 12 October 2016
First Online: 18 October 2016
Compliance with ethical standards
:
: Author Richard Harrop is employed by Oxford BioMedica who is developing 5T4-targeted therapies. Peter L. Stern is a consultant for Oxford BioMedica and has received speaker honoraria from Pfizer.
Free to read: This content has been made available to all.